Luisa Bracci - Concepedia

Author

Luisa Bracci

Also Known As

Bracci L, Bracci, L., Bracci, Luisa, Gian Rossolini, L Bracci, L. Bracci, L. bracci, Lisa Bracci, Luisa BRACCI, Luisa Bracci

202

Publications

4.2K

Citations

H-Index

140

Concepts

All Affiliations

University of Siena Toscana Life Sciences University of Florence University of Pisa University of Naples Federico II

About

Luisa Bracci is an author at University of Siena specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	41	1.5K
2	Natural Sciences	12	13	447
3	Engineering	8	8	219
4	Health Sciences	3	3	113
5	Public Health	1	1	29

Luisa Bracci

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients Emanuele Andreano, Emanuele Nicastri, Ida Paciello, Cell ImmunologyAntibody ScreeningAntibody EngineeringImmunotherapyMedicine	2021	237
Synthetic Peptides in the Form of Dendrimers Become Resistant to Protease Activity Luisa Bracci, Chiara Falciani, Barbara Lelli, Journal of Biological Chemistry	2003	172
Antimicrobial Activity of Novel Dendrimeric Peptides Obtained by Phage Display Selection and Rational Modification Alessandro Pini, Andrea Giuliani, Chiara Falciani, Antimicrobial Agents and Chemotherapy Peptide EngineeringAntibacterial ActivityDrug ResistancePeptide StabilityNovel Dendrimeric Peptides	2005	128
Identification of an Antiangiogenic FGF2-binding Site in the N Terminus of the Soluble Pattern Recognition Receptor PTX3 Maura Camozzi, Marco Rusnati, Antonella Bugatti, Journal of Biological Chemistry	2006	108
<p>Antimicrobial Peptide-Loaded Nanoparticles as Inhalation Therapy for <em>Pseudomonas aeruginosa</em> Infections</p> Chiara Falciani, Fabrizia Zevolini, Jlenia Brunetti, International Journal of Nanomedicine	2020	101
Therapeutic Activity of an Engineered Synthetic Killer Antiidiotypic Antibody Fragment against Experimental Mucosal and Systemic Candidiasis Luciano Polonelli, Walter Magliani, Stefania Conti, Infection and Immunity EngineeringMicrobial PathogensImmunologyGlycobiologyTherapeutic Activity	2003	100
Molecular Basis of Branched Peptides Resistance to Enzyme Proteolysis Chiara Falciani, Luisa Lozzi, Alessandro Pini, Chemical Biology & Drug Design	2007	97
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate Jlenia Brunetti, Chiara Falciani, Giulia Roscia, Scientific Reports	2016	84
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock <i>in vivo</i> Alessandro Pini, Chiara Falciani, Elisabetta Mantengoli, The FASEB Journal	2009	82
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens Chiara Falciani, Luisa Lozzi, Simona Pollini, PLoS ONE Microbial PathogensIsomeric VersionAntibiotic AdjuvantBacterial PathogensDrug Resistance	2012	81

Page 1